Related Experiment Video
Updated: May 7, 2026

09:30
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
2.2K
Fully automatic rapid DNA Ploidy Analyzer for intraoperative rapid diagnosis support
Summary
A new automated DNA ploidy analyzer offers rapid, quantitative tumor grading. This system accurately identifies glioma presence in surgical biopsies, improving diagnostic speed and accuracy.
Area of Science:
- Oncology
- Biotechnology
- Medical Diagnostics
Background:
- Frozen section analysis is crucial for tumor assessment but can be subjective.
- A quantitative method for intraoperative tumor grading is needed to complement histopathology.
- Previous work introduced intraoperative flow cytometry (iFC) to aid frozen section examination.
Purpose of the Study:
- To develop and evaluate an advanced automated system for rapid DNA ploidy analysis.
- To assess the system's utility in intraoperative glioma diagnosis and grading.
- To provide a quantitative measure of tumor malignancy during surgery.
Main Methods:
- Development of a "Fully Automatic Rapid DNA Ploidy Analyzer" with tissue pretreatment and freeze-dried reagents.
- Analysis of glioma patient biopsy samples during open surgery.
- Calculation of Malignancy Index (MI) and correlation with histological grade (WHO).
Main Results:
- Significant difference in Malignancy Index (MI) between neoplastic and perilesional brain tissue (26.0% vs 4.1%, P<0.001).
- Optimal cut-off MI of 6.8% achieved 86% sensitivity and 81% specificity for tumor identification.
- Good correlation observed between MI and WHO histological grade.
- Complete analysis from sample preparation to result in under ten minutes.
Conclusions:
- The automated DNA ploidy analyzer is a feasible tool for rapid glioma detection in surgical biopsies.
- The system provides quantitative data (MI) that correlates with tumor malignancy and histological grade.
- This technology enhances intraoperative decision-making by offering rapid, objective tumor assessment.

